Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
As AI continues to make a profound impact on the medical imaging industry, the FDA is hosting a two-day public workshop to discuss the benefits and risks of this powerful technology.
A new international partnership is focused on using AI technology to take a closer look at the human brain and advance amyotrophic lateral sclerosis (ALS) research.
After poring over the chemical compositions of more than 107 million molecules used to make all sorts of drugs, a machine learning algorithm has plucked out one unexpected candidate that may be medicine’s best hope yet against dreaded superbugs.
Healthcare AI giant IBM Watson Health has introduced software that can help medical researchers design clinical studies right the first time so as to minimize the need for tweaking and fine-tuning while their study is underway.
Researchers have developed two AI-powered tools for automatically extracting key information from free-text pathology reports. The team shared its findings in the Journal of the American Medical Informatics Association.
Machine learning-based CT texture analysis can help with the evaluation of solid renal masses, according to new findings published in Academic Radiology. Could this help reduce the number of patients undergoing unnecessary surgeries?
